Three-dimensional mapping of hippocampal anatomy in unmedicated and lithium-treated patients with bipolar disorder
| Contribuinte(s) |
UNIVERSIDADE DE SÃO PAULO |
|---|---|
| Data(s) |
19/10/2012
19/10/2012
2008
|
| Resumo |
Declarative memory impairments are common in patients with bipolar illness, suggesting underlying hippocampal pathology. However, hippocampal volume deficits are rarely observed in bipolar disorder. Here we used surface-based anatomic mapping to examine hippocampal anatomy in bipolar patients treated with lithium relative to matched control subjects and unmedicated patients with bipolar disorder. High-resolution brain magnetic resonance images were acquired from 33 patients with bipolar disorder ( 21 treated with lithium and 12 unmedicated), and 62 demographically matched healthy control subjects. Three-dimensional parametric mesh models were created from manual tracings of the hippocampal formation. Total hippocampal volume was significantly larger in lithium-treated bipolar patients compared with healthy controls (by 10.3%; p=0.001) and unmedicated bipolar patients ( by 13.9%; p=0.003). Statistical mapping results, confirmed by permutation testing, revealed localized deficits in the right hippocampus, in regions corresponding primarily to cornu ammonis vertical bar subfields, in unmedicated bipolar patients, as compared to both normal controls (p=0.01), and in lithium-treated bipolar patients (p=0.03). These findings demonstrate the sensitivity of these anatomic mapping methods for detecting subtle alterations in hippocampal structure in bipolar disorder. The observed reduction in subregions of the hippocampus in unmedicated bipolar patients suggests a possible neural correlate for memory deficits frequently reported in this illness. Moreover, increased hippocampal volume in lithium-treated bipolar patients may reflect postulated neurotrophic effects of this agent, a possibility warranting further study in longitudinal investigations. |
| Identificador |
NEUROPSYCHOPHARMACOLOGY, v.33, n.6, p.1229-1238, 2008 0893-133X http://producao.usp.br/handle/BDPI/23549 10.1038/sj.npp.1301507 |
| Idioma(s) |
eng |
| Publicador |
NATURE PUBLISHING GROUP |
| Relação |
Neuropsychopharmacology |
| Direitos |
closedAccess Copyright NATURE PUBLISHING GROUP |
| Palavras-Chave | #mood disorder #magnetic resonance imaging #hippocampus #medication effects #neurotrophins #brain mapping #MILD COGNITIVE IMPAIRMENT #MANIC-DEPRESSIVE ILLNESS #N-ACETYL-ASPARTATE #GRAY-MATTER #MOOD DISORDERS #HUMAN BRAIN #IN-VIVO #ALZHEIMERS-DISEASE #PROTEIN BCL-2 #SCHIZOPHRENIA #Neurosciences #Pharmacology & Pharmacy #Psychiatry |
| Tipo |
article proceedings paper publishedVersion |